Table 3.
Multivariable Cox regression analyses.
| Parameter | Endpoint death/HTx/AF |
Endpoint death/HTx |
||||
|---|---|---|---|---|---|---|
| adjusted HRa | 95% CI | p value | adjusted HRa | 95% CI | p value | |
| IAB vs. no IAB (n = 182) | 1.88 | 1.22–2.89 | 0.004 | 2.05 | 1.23–3.41 | 0.006 |
| pIAB vs. no IAB (n = 163) | 1.86 | 1.16–2.97 | 0.010 | 1.88 | 1.08–3.27 | 0.026 |
| aIAB vs. no IAB (n = 122) | 2.39 | 1.16–4.92 | 0.018 | 2.44 | 1.08–5.52 | 0.032 |
| aIAB vs. pIAB (n = 79) | 0.91 | 0.43–1.94 | 0.804 | 1.07 | 0.45–2.52 | 0.878 |
| Abnormal PTFV1 vs. normal PTFV1 (n = 182) | 1.09 | 0.69–1.73 | 0.707 | 1.16 | 0.67–1.99 | 0.598 |
Time from CRT implantation. Follow-up is 5 years. Tde reference variables are no IAB and normal PTFV1
Adjusted for age, NYHA Class, ischemic etiology of HF, LBBB, LVEF, CRT-P vs. CRT-D.